David A. Siegel Xencor Inc Transaction History

Two Sigma Advisers, LP

$42.5 Billion
Q1 2024

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Xencor Inc stock. As of the latest transaction made, Two Sigma Advisers, LP holds 601,900 shares of XNCR stock, worth $11.4 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

601,900

Previous 319,200 88.57%

Holding current value

$11.4 Million

Previous $6.78 Million 96.58%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$18.65 - $26.52 $5.27 Million - $7.5 Million	282,700 Added 88.57%	601,900 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$16.53 - $21.42 $1.41 Million - $1.82 Million	85,100 Added 36.35%	319,200 $6.78 Million
Q3 2023 Nov 14, 2023	BUY	$20.08 - $25.39 $293,168 - $370,694	14,600 Added 6.65%	234,100 $4.72 Million
Q2 2023 Aug 14, 2023	BUY	$24.77 - $29.9 $430,998 - $520,260	17,400 Added 8.61%	219,500 $5.48 Million
Q1 2023 May 15, 2023	BUY	$25.95 - $36.95 $731,790 - $1.04 Million	28,200 Added 16.22%	202,100 $5.64 Million

Q4 2022 Feb 14, 2023	BUY	$24.79 - $30.86 $1.65 Million - $2.06 Million	66,600 Added 62.07%	173,900 $4.53 Million
Q3 2022 Nov 14, 2022	BUY	$24.62 - $32.44 $1.26 Million - $1.65 Million	51,000 Added 90.59%	107,300 $2.79 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $29.01 $659,316 - $968,934	33,400 Added 145.85%	56,300 $1.54 Million
Q1 2022 May 16, 2022	BUY	$26.68 - $41.63 $610,972 - $953,327	22,900 New	22,900 $611,000
Q4 2021 Feb 14, 2022	SELL	$33.67 - $43.44 $252,525 - $325,800	-7,500 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$30.65 - $35.68 $1.31 Million - $1.53 Million	-42,900 Reduced 85.12%	7,500 $245,000
Q2 2021 Aug 16, 2021	SELL	$34.33 - $44.68 $236,877 - $308,292	-6,900 Reduced 12.04%	50,400 $1.74 Million
Q1 2021 May 17, 2021	BUY	$40.81 - $53.88 $1.32 Million - $1.75 Million	32,400 Added 130.12%	57,300 $2.47 Million
Q4 2020 Feb 16, 2021	BUY	$36.63 - $47.63 $311,355 - $404,855	8,500 Added 51.83%	24,900 $1.09 Million
Q3 2020 Nov 16, 2020	SELL	$30.09 - $43.02 $234,702 - $335,556	-7,800 Reduced 32.23%	16,400 $636,000
Q2 2020 Aug 14, 2020	BUY	$27.76 - $33.42 $671,792 - $808,764	24,200 New	24,200 $784,000
Q2 2019 Aug 14, 2019	SELL	$29.6 - $40.93 $364,080 - $503,439	-12,300 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $646,120 - $883,688	-23,200 Reduced 65.35%	12,300 $382,000
Q4 2018 Feb 14, 2019	SELL	$32.39 - $42.05 $440,504 - $571,880	-13,600 Reduced 27.7%	35,500 $1.28 Million
Q3 2018 Nov 14, 2018	SELL	$35.69 - $47.65 $1.06 Million - $1.42 Million	-29,800 Reduced 37.77%	49,100 $1.91 Million
Q2 2018 Aug 14, 2018	BUY	$28.41 - $42.41 $1.45 Million - $2.17 Million	51,100 Added 183.81%	78,900 $2.92 Million
Q1 2018 May 15, 2018	BUY	$21.18 - $33.78 $319,818 - $510,078	15,100 Added 118.9%	27,800 $833,000
Q4 2017 Feb 14, 2018	BUY	$19.29 - $24.83 $244,983 - $315,341	12,700	12,700 $278,000

Others Institutions Holding XNCR

# of Institutions

203

Shares Held

64M

Call Options Held

2.2K

Put Options Held

1.3K

View Full List

About Xencor Inc

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.13B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

More about XNCR

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account